Processa Pharmaceuticals, Inc. ( PCSA) - Key Metrics
PCSA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$1.29 | -$1.37 | -$1.37 |
| 2025Q4 | $0 | -$1.31 | -$1.13 | -$1.13 |
| 2025Q3 | $0 | -$1.81 | -$1.83 | -$1.83 |
| 2025Q2 | $0 | -$6.32 | -$3.65 | -$3.65 |
| 2025Q1 | $0 | -$7.44 | -$7.16 | -$7.16 |
PCSA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -0.49 |
| 2025Q4 | 0% | -0.55 |
| 2025Q3 | 0% | -0.66 |
| 2025Q2 | 0% | -0.21 |
| 2025Q1 | 0% | -0.31 |
PCSA
Price: $2.10
52 week price:
Earnings Per Share: -3.96 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 125600
Market Capitalization: 8.6 million